Drugging the Undruggable RAS in Pancreatic Cancer
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
By:
Summary
This summer, a new targeted treatment for pancreatic cancer was approved by the FDA. The treatment, Rasonque (daraxonrasib), is giving new hope to people with a disease that had been seen as almost untreatable. In this episode, Chuck and Alicia unpack this new development with Dr. Brian Wolpin, director of the Hale Family Center for Pancreatic Cancer Research at Dana-Farber Cancer Institute, who led the drug trial.
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.